Physician profile
Anthony Digirolamo
NPI 1356781835
$2,427.97
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,246 · 2020: $282 · 2021: $276 · 2022: $189 · 2023: $290 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,222.35 | 2019-2024 | Senza |
| Abbott Laboratories | $241.48 | 2019-2023 | Eterna |
| Abbvie INC. | $138.19 | 2023-2024 | Ubrelvy, Qulipta |
| Bioventus LLC | $137.49 | 2021-2023 | Durolane |
| Ferring Pharmaceuticals INC. | $106.62 | 2020-2023 | Euflexxa |
| Nalu Medical, INC. | $95.91 | 2021-2024 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $67.67 | 2019-2021 | |
| Pfizer INC. | $57.41 | 2019 | |
| Relievant Medsystems, INC. | $54.28 | 2021 | |
| Pacira Therapeutics, INC. | $38.17 | 2019-2021 | |
| Convatec INC. | $32.80 | 2023 | |
| Medtronic USA, INC. | $29.90 | 2019-2020 | |
| Boston Scientific Corporation | $29.36 | 2023 | Wavewriter Alpha Prime 16 |
| Mml US, INC. | $29.18 | 2023 | Reactiv8 |
| Amgen INC. | $28.52 | 2024 | Prolia, Evenity |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $25.58 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $21.93 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $18.71 | 2024 | Dysport |
| Joint Active Systems, INC. | $14.33 | 2021 | |
| Stratus Medical, LLC | $13.67 | 2023 | Nimbus |
| Biodelivery Sciences International, INC. | $13.43 | 2020 | |
| Scilex Pharmaceuticals INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Digirolamo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.